BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ · Healthcare
BridgeBio Oncology Therapeutics, Inc. Balance Sheet 2023–2025
| Dec 2025 | Dec 2024 | Dec 2023 | |
|---|---|---|---|
| Assets | |||
| Total Assets | 448.4M | 164.3M | 5.9M |
| Cash & Equivalents | 373.7M | 30.9M | 250,000 |
| Liabilities | |||
| Total Liabilities | 37.3M | 342.9M | 121.6M |
| Long-Term Debt | 2.2M | — | — |
| Equity | |||
| Shareholders' Equity | 411.1M | -178.6M | -115.6M |
BridgeBio Oncology Therapeutics, Inc. Balance Sheet — FAQ
BridgeBio Oncology Therapeutics, Inc. (BBOT) balance sheet over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see BBOT's balance sheet history?
The chart and table above show BridgeBio Oncology Therapeutics, Inc.'s balance sheet by year and by quarter, including the growth rate.